A bacterial suppressor tRNA gene was introduced into the long terminal repeat of the Maloney murine leukemia virus (Mo-MuLV) proviral genome to construct a retrovirus that allows easy cloning of the provirus with flanking host sequences. A replication competent virus, Mo-Mu-LVSUP containing a tRNA amber suppressor gene, was derived that replicates to high titers in tissue culture cells and stably transduces the bacterial gene. have not yet revealed any specificity on the level of the host DNA sequence, and it is possible that other and unknown levels of chromosomal organization influence the site of provirus insertion. Clearly, the elucidation of the mechanism of integration, of position dependent expression, and of insertional mutagenesis requires molecular cloning of the provirus together with flanking sequences. However, the recovery of proviral integration sites in the mouse is hampered by the extensive homology between the multiple murine endogenous and exogenous retroviruses, which complicates the screening in conventional cloning procedures. Recently, Mo-MuLV-based vector systems have been devised that make use of bacterial selectable markers and replication origins, thus allowing direct rescue of integrated viral copies in E. coli (9). In these systems the vector itself is replication defective and, thus, requires a replication-competent helper virus for its own propagation. This limits its use for in vivo experiments, where efficient virus replication and virus spread are needed to infect different animal tissues (10).
The stable association of proviral DNA with the host chromosomnes is part of the normal life cycle of retroviruses (1) . Although retroviruses carry their own regulatory signals, virus expression appears to depend also on cellular control mechanisms. Thus, substrains of mice which carry the Moloney murine leukemia virus (Mo-MuLV) as a Mendelian determinant at different chromosomal loci differ in their phenotype of virus expression: some mouse strains show no virus expression, while others activate virus at different stages of development (2, 3) . This suggested that the same gene in different chromosomal environments may become activated differentially during development. Furthermore, retroviruses capable of inserting into many chromosomal regions are able to affect expression of cellular genes. This can result in the inactivation of adjacent genes by insertional mutagenesis (4-7) or in enhancement of transcription as seen in the activation of cellular oncogenes (8) .
The general question of how a retrovirus selects its target site is far from being solved. Analyses of integration sites have not yet revealed any specificity on the level of the host DNA sequence, and it is possible that other and unknown levels of chromosomal organization influence the site of provirus insertion. Clearly, the elucidation of the mechanism of integration, of position dependent expression, and of insertional mutagenesis requires molecular cloning of the provirus together with flanking sequences. However, the recovery of proviral integration sites in the mouse is hampered by the extensive homology between the multiple murine endogenous and exogenous retroviruses, which complicates the screening in conventional cloning procedures. Recently, Mo-MuLV-based vector systems have been devised that make use of bacterial selectable markers and replication origins, thus allowing direct rescue of integrated viral copies in E. coli (9) . In these systems the vector itself is replication defective and, thus, requires a replication-competent helper virus for its own propagation. This limits its use for in vivo experiments, where efficient virus replication and virus spread are needed to infect different animal tissues (10) .
In this report we describe a replication competent MoMuLV vector that efficiently replicates in animals and can be directly selected in bacteria after packaging in phage X. Furthermore, the use of phage X as bacterial vector assures high cloning efficiency and a high capacity to recover cellular sequences flanking the provirus.
MATERIALS AND METHODS
Plasmid Constructions, DNA Isolation, and Blotting. Restriction enzymes were purchased from Boehringer Mannheim, Bethesda Research Laboratories, and New England Biolabs and were used under recommended conditions. DNA-fragments were purified on 0.5-2% agarose gels and Na-45 ion-exchange membranes (Schleicher & Schull). Ligations were performed with T4 DNA ligase (Bethesda Research Laboratories) at DNA concentrations of 100-200 ,ug/ml. Linker reactions (linkers supplied by Boehringer Mannheim and P-L Biochemicals), transfection into E. coli HB 101 or DP 54, and plasmid growth were done by standard methods (11) . Isolation of DNA from tissue culture cells and mouse organs, DNA blotting, and hybridization with [32P]DNA labeled by nick translation have been described (2, 12) .
Transfection and Infection of Cells. Plasmids pMosuP-1, -2, -3, and -4 (see legend to Fig. 1 ) were digested with Cla I, and the proviral inserts were isolated and ligated. NIH 3T3 cells were transfected with 2 ,g of ligated plasmid DNA and pSV2-gpt DNA (13) at a molar ratio of 1:3 and with 30 ,g of carrier DNA as described (12) . Two days after transfection the cells were trypsinized and plated into selective medium containing mycophenolic acid (13) and assayed for virus production by the XC plaque assay (12) .
NIH 3T3 cells were infected with filtrated supernatant at a multiplicity of infection of 2-4. The embryonal carcinoma cell line PCC4 (14) was infected by cocultivation for 6 days with mitomycin C-treated 3T3 cells (10 phage X was done by described procedures (11, 16 (19) with EcoRI and ligated to BamHI or Xba I linkers, thereby removing the EcoRI sites. 3' long terminal repeat (LTR) subclones derived from the infectious pMov-3 (16), extending from the Cla I site in env to the 3' end of the LTR, were used to insert the tRNA gene. The first two modified LTRs were derived by introduction of the suppressor tRNA gene, provided with Xba I ends, in either orientation into the Xba I site 3' of the enhancer sequences in the LTR (pLTRsuP-4 in the same and pLTRsuP-3 in the opposite transcriptional sense of the viral DNA). Other constructs were obtained by first converting the Sau3A site upstream of the enhancer with linkers into a BamHI site and then inserting the tRNA gene carrying terminal BamHI sites in either orientation into this site (pLTRsuP-2 in the same and pLTRsuP-1 in the opposite transcriptional sense) (Fig. 1) .
The next step was the substitution of the wild-type MoMuLV (Mo-MuLVwt) LTR with the four different modified LTRs in a plasmid containing a circularly permuted copy of an infectious Mo-MuLV provirus (see Fig. 1 ). The inserts of the resulting four circular permuted Mo-MuLVsuP clones (pMosuP-1, pMosuP-2, pMosuP-3, pMosuP-4) were released by Cla I treatment, purified on agarose gels, and ligated in vitro to produce polymers ( Fig. 1) . In vitro ligated fragments were cotransfected with pSV2-gpt using NIH 3T3 cells as recipients. Mycophenolic acid-resistant cells were grown to confluency and tested for viru's production by the XC plaque assay. All four constructs were shown to be infectious in this assay.
Production of Infectious Virus and Stability in Tissue Culture Cells. To test whether Mo-MuLVsuP would be infectious for different cell types and whether the suppressor gene was stably transmitted in the Mo-MuLV genome throughout complete replication cycles of the virus, we infected NIH 3T3 and PCC4 cells. After several passages, high molecular DNA was isolated from the cells and subjected to Southern blot analysis. To distinguish between the LTRs of MoMuLVWt and Mo-MuLVsuP, we performed a Kpn I digestion, which produces a 3' LTR fragment of 1.28 kilobases (kb) and 1.48 kb, respectively. As expected, the 1.48-kb Kpn I fragments reacted with the labeled suppressor probe, whereas the 1.28-kb fragments did not ( Fig. 2A, lanes g-j; Fig. 2B , lane c), suggesting deletion of the suppressor gene. The Mo-MuLVsuP-1 virus was stable in two subsequent rounds of virus infection, whereas the fraction of the deletion variant increased with each passage of the Mo-MuLVsuP-3 virus stock (data not shown). This indicated that the deletion variant had a replication advantage over the suppressor-containing virus.
Mo-MuLVsuP-1-infected 3T3 cells produced a titer of 106/ml of infectious virus, which is similar to the titer produced by cells chronically infected with Mo-MuLVwt. No virus production was observed in Mo-MuLVsuP-1-infected PCC4 cells, indicating that the modified virus, like MoMuLVWt (15) , cannot replicate in embryonal carcinoma cells.
Selective Cloning of Mo-MuLVs"P Proviral Copies. To show that not only the suppressor sequence but also the desired function was retained in the viral genome, we performed two independent cloning experiments. From 3T3 cells infected with Mo-MuLVsuP-1 or -3 (Fig. 2) , DNA containing approximately five proviral copies per cell was cleaved with EcoRI, which does not cut Mo-MuLV proviral DNA. After ligation to phage X Charon 4A arms carrying amber mutations andin vitro packaging into phage particles, su+ and sue E. coli cells were infected. grew under selective conditions on the su-host. These numbers indicate a high efficiency of recovery of the retroviral integration sites, considering the average size of clonable EcoRI fragments, the size of the murine genome, and the average number of proviral copies in the infected 3T3 cells. All of the selected plaques showed hybridization to a MoMuLV probe and to a suppressor probe ( Table 1 ), indicating that the applied selection scheme is highly specific. Integrated complete Mo-MuLVsuP genomes could be recovered since EcoRI, a noncutter for Mo-MuLV, was used for cloning. Fig. 3 shows a Southern blot analysis of 10 phage clones that were digested with Sst I and hybridized with a representative Moloney probe. A 5.8-kb and a 2.6-kb fragment, which are characteristic for the Mo-MuLVsuP proviral genome (Fig. 3, lane k) , were seen in four clones, whereas the other six clones contained rearranged Mo-MuLV genomes. Two of the nonrearranged clones were transferred into NIH 3T3 cells and gave rise to infectious virus, indicating that they contained an intact Mo-MuLV genome.
The total size of the insert was between 12 and 18 kb as measured by agarose gel electrophoresis, indicating that between 3 and 9 kb of flanking host sequences were recovered. Unique and repetitive cellular sequences were present in the clones as demonstrated by hybridizing to genomic libraries (data not shown).
Replication of Mo-MuLVsP-l in Embryos and Newborn Mice. To analyze the stability and the replication properties of Mo-MuLVsuP in vivo, we infected embryos and newborn mice with virus. Embryos were microinjected with 3T3 cells producing Mo-MuLVsuP-1 at day 8.5 of gestation (17) , and newborns were infected by intraperitoneal injection of MoMuLVsuP-1 virus. Results on induction of viremia, as tested by radioimmunoassay for p30, are summarized in Table 2 . The data show that >90% of the infected animals developed viremia, indicating efficient virus replication in vivo.
The structure of integrated proviral genomes and their tissue distribution were determined by Southern blotting. Fig.  4A shows a Kpn I digest of DNA extracted from six newborns infected at day 8.5 of gestation. Different organs i.e., liver, heart, kidney, lung, brain, spleen, and thymus (Fig. 4A, lanes a-g) -were pooled, and carcasses were analyzed individually (lanes h-m). All carcasses and all tissues examined revealed the presence of the 1.48-kb Kpn I band Embryos were injected at day 8.5 of gestation with Mo-MuLVsuP-1 virus-producing cells (17) , and postnatal mice were injected intraperitoneally with virus. The animals were tested for viremia (18) diagnostic for the 3' LTR fragment of Mo-MuLVsuP, the band being most prominent in liver, kidney, and spleen (Fig.  4A, lanes a, c, and f) . However, the carcass from animal no. 2 (Fig. 4A, lane i) and liver, kidney, lung, and spleen (lanes a, c, d, and f) showed an additional band comigrating with the corresponding Mo-MuLVwt fragment (lane n). Fig. 4B shows the Southern blot analysis of DNA from individual organs of a mouse injected at day 8.5 of gestation and sacrificed at age 8 wk. Again, the organs spleen, thymus, liver, brain, and kidney (Fig. 4B, lanes a-e) showed the characteristic 1.48-kb Kpn I band. As in Fig. 4A , the smaller band of approximately wt size was detected at a low level.
Mice infected as newborns were investigated by the same procedure. In all three analyzed mice, spleen and thymus were permissive for replication of Mo-MuLVsuP-1 and, thus, showed the 1.48-kb Kpn I fragment (Fig. 5, lanes a, b, f, g the observed instability of the recombinant virus is not specific for certain organs or the developmental stage at which the animals were infected. Its appearance and extent seem to be variable from animal to animal.
In summary, these results show that Mo-MuLVsuP-1 closely resembles Mo-MuLVwt in its replication properties in vivo (10) . All fetal tissues become infected efficiently, whereas virus replication is restricted to spleen and thymus when the mice are infected after birth. The suppressor tRNA gene is lost from the virus with a low frequency when replicating in animals but appears to be stable when the virus replicates in tissue culture cells (Fig. 2) .
DISCUSSION
Molecular cloning of integrated Mo-MuLV as a means to study biological properties of the virus and characterize cellular integration sites has been a laborious procedure. Crossreaction of available Mo-MuLV probes to endogenous viruses and the need for multiple rounds of recombinant phage purification have hampered the rapid and efficient recovery of clones.
We have circumvented these problems by introducing an amber suppressor tRNA gene as a selectable marker into the LTRs of Mo-MuLV. Four constructs were obtained having the tRNA gene incorporated in either orientation 5' or 3' of the enhancer sequences in the Moloney LTR. After transfection into NIH 3T3 cells, these constructs produced infectious virus. The proviral copies could be recovered from infected cells by molecular cloning in X phages by using the tRNA gene as a selectable marker in E. coli. The selection system was very efficient, as demonstrated by the high number of clones obtained per genome equivalent, and was highly specific because all selected clones contained Mo-MuLV proviral sequences. Because of the size requirements for packaging in phage particles, between 1 and 11 kb of flanking sequences are recovered with each provirus. Thus, genomic flanking sequences can be cloned with higher efficiency as compared to plasmid-derived "shuttle" vectors constructed for this purpose (9) . In our experiments using a bacterial strain with a high recombination frequency, a considerable fraction of the recombinant phages contained rearranged Mo-MuLVsuP sequences. It is likely that rearrangements can be minimized by using a recombination-deficient su-host for the suppressor selection.
All four Mo-MuLVsuP viruses were able to replicate in NIH 3T3 cells. However, only one construct, Mo-MuLVsuP-1, was stable during three cycles of infection and produced a virus titer comparable to Mo-MuLVwt. The other Mo-Mu-LVSUP viruses lost the suppressor gene at different frequencies.
When injected into midgestation embryos or newborn mice, Mo-MuLVsuP-1 induced viremia efficiently. Analyses of the tissue distribution of the proviral sequences revealed that Mo-MuLVsuP-1 is able to replicate in all fetal tissues when introduced at midgestation and in spleen and thymus when injected postnatally. Thus, Mo-MuLVsuP retains the characteristic tissue tropism of Mo-MuLVw` (10) . At present we do not know whether viremic animals develop neoplastic disease at later stages.
Although no instability of Mo-MuLVsuP-1 was detected in tissue culture, the suppressor gene was deleted at a low frequency in animals. The apparently different stability of the four Mo-MuLVsuP constructs seems to depend on the orientation and location of the suppressor gene in the LTR. Remarkably, the two least stable constructs, Mo-MuLVsuP-2 and -4, contain the suppressor gene in the same transcriptional orientation as the virus [the noncoding (+)-strand is part of the viral RNA], suggesting a role of RNA secondary 1144 Cell Biology: Reik et aL .7 structure in the deletion process. Another possible mechanism could involve homologous recombination across the linker sequences within the LTR. This explanation is supported by the finding that, within the limits of resolution, the deletion products are very similar in size to the Mo-MuLVwt genome. Once the deletion variant has formed, it appears to outgrow the Mo-MuLVsuP virus due to a replication advantage.
The described Mo-MuLVsuP-1 virus represents a powerful tool for studying parameters in virus-host chromosome interactions. These interactions may include the recognition of a specific sequence, as in the case of a transposable element in Drosophila that codes for a protein with homology to reverse transcriptase (21) . Moreover, a change of chromatin conformation after retrovirus insertion close to a hypersensitive site has been reported recently (22) . To test the general significance of this finding, it will be necessary to clone a number of different integration sites in order to analyze their chromatin organization. Finally, this virus will be useful in studies on developmentally regulated, cell type-specific interactions of retroviruses in animals as well as in retroviral mutagenesis experiments (4, 6) by facilitating the cloning of the flanking sequences. 
